Skip to main content

Table 1 Patients’ clinicopathological characteristics

From: Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group’s analysis

Characteristics N = 100
Agea 68,49 (62–78)
Gender
M 64 (64%)
F 36 (36%)
Tumor location
Upper 10 (10%)
Body 38 (38%)
Lower 47 (47%)
Linitis 5 (5%)
Gastrectomy
Total 42 (42%)
Subtotal 58 (58%)
Lymphadenectomy
D1 36 (36%)
D2 46 (46%)
+ 18 (18%)
HIPEC
Yes 11 (11%)
No 89 (89%)
Adjuvant chemotherapyb
Yes 42 (42%)
No 35 (35%)
Surgical radicalityb
0 38 (38%)
1 18 (18%)
2 43 (43%)
pT
1 0
2 2 (2%)
3 32 (32%)
4a 54 (54%)
4b 12 (12%)
pN
0 2 (2%)
1 7 (7%)
2 14 (14%)
3 71 (71%)
x 6 (6%)
Lymph nodes harvestedb 40.85 (28–53)
Peritoneal involvementb
P1 34 (34%)
P2 17 (17%)
P3 23 (23%)
Lauren’s typeb
Intestinal 37 (37%)
Diffuse 46 (46%)
Mixed 16 (16%)
  1. aIndicated as mean and 25th–75th percentile of value
  2. bSome data are missing